T-Cypher Bio is an early-stage biotechnology company. T-Cypher Bio we believe that TCR-based therapeutics have the potential to transform the treatment of solid tumors, as well as autoimmune, inflammatory, and infectious diseases. Yet challenges in the identification of therapeutically relevant targets and TCRs have limited the application of suchtherapies.T-Cypher’s integrated platform, D-Cypher, overcomes these challenges.

Biotechnology

T-Cypher Bio

T-Cypher Bio's headquarters in Oxford, United Kingdom

Description

People (16)

Hemza Ghadbane

Mark Lees

Nathaniel Davies

David Cook

Dominic Hine

Eleanor Bagg

Juan Hernando Bolivar Gonzalez

Maria Busz

Samantha Drennan

Samhita Rao

Xiao-yan Pan

Sarah Leonard

Jana Rundle

Samuel Ward

Michela Marongiu

Amalia Martínez Segura

Jobs